Biomarkers associated with aortic valve calcification: should we focus on sex specific processes?

Research output: Contribution to journalArticlepeer-review

Standard

Biomarkers associated with aortic valve calcification : should we focus on sex specific processes? / Peeters, Frederique; Dudink, Elton A. M. P.; Weijs, Bob ; Fabritz, Larissa; Chua, Winnie Wei Ling; Kietselaer, Bas L. ; Wildberger, Joachim; Meex, Steven; Kirchhof, Paulus; Crijns, Harry J G M; Schurgers, Leon.

In: Frontiers in cell and developmental biology, Vol. 8, 604, 10.07.2020.

Research output: Contribution to journalArticlepeer-review

Harvard

APA

Vancouver

Author

Peeters, Frederique ; Dudink, Elton A. M. P. ; Weijs, Bob ; Fabritz, Larissa ; Chua, Winnie Wei Ling ; Kietselaer, Bas L. ; Wildberger, Joachim ; Meex, Steven ; Kirchhof, Paulus ; Crijns, Harry J G M ; Schurgers, Leon. / Biomarkers associated with aortic valve calcification : should we focus on sex specific processes?. In: Frontiers in cell and developmental biology. 2020 ; Vol. 8.

Bibtex

@article{cce4df1c24f846d499dc29bac2991b49,
title = "Biomarkers associated with aortic valve calcification: should we focus on sex specific processes?",
abstract = "Objective: Circulating biomarkers are useful in detection and monitoring of cardiovascular diseases. However, their role in aortic valve disease is unclear. Mechanisms are rapidly elucidated and sex differences are suggested to be involved. Therefore, we sought to identify biomarkers involved in aortic valve calcification (AVC) stratified by sex.Methods: Blood samples of 34 patients with AVC (without further overt cardiovascular disease, including absence of hemodynamic consequences of valvular calcification) were compared with 136 patients without AVC. AVC was determined using computed tomography calcium scoring. Circulating biomarkers were quantified using a novel antibody-based method (Olink Proseek Multiplex Cardiovascular Panel I) and 92 biomarkers were compared between patients with and without AVC.Results: In the overall population, Interleukin-1 Receptor Antagonist and pappalysin-1 were associated with increased and decreased odds of having AVC. These differences were driven by the male population [IL1RA: OR 2.79 (1.16–6.70), p = 0.022; PAPPA: OR 0.30 (0.11–0.84), p = 0.021]. Furthermore, TNF-related activation-induced cytokine (TRANCE) and fibroblast growth factor-23 were associated decreased odds of having AVC, and monocyte chemotactic protein-1 was associated with increased odds of having AVC [TRANCE: OR 0.32 (0.12–0.80), p = 0.015; FGF23: OR 0.41 (0.170–0.991), p = 0.048; MCP1: OR 2.64 (1.02–6.81), p = 0.045]. In contrast, galanin peptides and ST2 were associated with increased odds of having AVC in females [GAL: OR 12.38 (1.31–116.7), p = 0.028; ST2: OR13.64 (1.21–153.33), p = 0.034].Conclusion: In this exploratory study, we identified biomarkers involved in inflammation, fibrosis and calcification which may be associated with having AVC. Biomarkers involved in fibrosis may show higher expression in females, whilst biomarkers involved in inflammation and calcification could associate with AVC in males.",
keywords = "aortic valve calcification, biomarkers, sex-specific, fibrosis, inflammation",
author = "Frederique Peeters and Dudink, {Elton A. M. P.} and Bob Weijs and Larissa Fabritz and Chua, {Winnie Wei Ling} and Kietselaer, {Bas L.} and Joachim Wildberger and Steven Meex and Paulus Kirchhof and Crijns, {Harry J G M} and Leon Schurgers",
year = "2020",
month = jul,
day = "10",
doi = "10.3389/fcell.2020.00604",
language = "English",
volume = "8",
journal = "Frontiers in cell and developmental biology",
issn = "2296-634X",
publisher = "Frontiers Research Foundation",

}

RIS

TY - JOUR

T1 - Biomarkers associated with aortic valve calcification

T2 - should we focus on sex specific processes?

AU - Peeters, Frederique

AU - Dudink, Elton A. M. P.

AU - Weijs, Bob

AU - Fabritz, Larissa

AU - Chua, Winnie Wei Ling

AU - Kietselaer, Bas L.

AU - Wildberger, Joachim

AU - Meex, Steven

AU - Kirchhof, Paulus

AU - Crijns, Harry J G M

AU - Schurgers, Leon

PY - 2020/7/10

Y1 - 2020/7/10

N2 - Objective: Circulating biomarkers are useful in detection and monitoring of cardiovascular diseases. However, their role in aortic valve disease is unclear. Mechanisms are rapidly elucidated and sex differences are suggested to be involved. Therefore, we sought to identify biomarkers involved in aortic valve calcification (AVC) stratified by sex.Methods: Blood samples of 34 patients with AVC (without further overt cardiovascular disease, including absence of hemodynamic consequences of valvular calcification) were compared with 136 patients without AVC. AVC was determined using computed tomography calcium scoring. Circulating biomarkers were quantified using a novel antibody-based method (Olink Proseek Multiplex Cardiovascular Panel I) and 92 biomarkers were compared between patients with and without AVC.Results: In the overall population, Interleukin-1 Receptor Antagonist and pappalysin-1 were associated with increased and decreased odds of having AVC. These differences were driven by the male population [IL1RA: OR 2.79 (1.16–6.70), p = 0.022; PAPPA: OR 0.30 (0.11–0.84), p = 0.021]. Furthermore, TNF-related activation-induced cytokine (TRANCE) and fibroblast growth factor-23 were associated decreased odds of having AVC, and monocyte chemotactic protein-1 was associated with increased odds of having AVC [TRANCE: OR 0.32 (0.12–0.80), p = 0.015; FGF23: OR 0.41 (0.170–0.991), p = 0.048; MCP1: OR 2.64 (1.02–6.81), p = 0.045]. In contrast, galanin peptides and ST2 were associated with increased odds of having AVC in females [GAL: OR 12.38 (1.31–116.7), p = 0.028; ST2: OR13.64 (1.21–153.33), p = 0.034].Conclusion: In this exploratory study, we identified biomarkers involved in inflammation, fibrosis and calcification which may be associated with having AVC. Biomarkers involved in fibrosis may show higher expression in females, whilst biomarkers involved in inflammation and calcification could associate with AVC in males.

AB - Objective: Circulating biomarkers are useful in detection and monitoring of cardiovascular diseases. However, their role in aortic valve disease is unclear. Mechanisms are rapidly elucidated and sex differences are suggested to be involved. Therefore, we sought to identify biomarkers involved in aortic valve calcification (AVC) stratified by sex.Methods: Blood samples of 34 patients with AVC (without further overt cardiovascular disease, including absence of hemodynamic consequences of valvular calcification) were compared with 136 patients without AVC. AVC was determined using computed tomography calcium scoring. Circulating biomarkers were quantified using a novel antibody-based method (Olink Proseek Multiplex Cardiovascular Panel I) and 92 biomarkers were compared between patients with and without AVC.Results: In the overall population, Interleukin-1 Receptor Antagonist and pappalysin-1 were associated with increased and decreased odds of having AVC. These differences were driven by the male population [IL1RA: OR 2.79 (1.16–6.70), p = 0.022; PAPPA: OR 0.30 (0.11–0.84), p = 0.021]. Furthermore, TNF-related activation-induced cytokine (TRANCE) and fibroblast growth factor-23 were associated decreased odds of having AVC, and monocyte chemotactic protein-1 was associated with increased odds of having AVC [TRANCE: OR 0.32 (0.12–0.80), p = 0.015; FGF23: OR 0.41 (0.170–0.991), p = 0.048; MCP1: OR 2.64 (1.02–6.81), p = 0.045]. In contrast, galanin peptides and ST2 were associated with increased odds of having AVC in females [GAL: OR 12.38 (1.31–116.7), p = 0.028; ST2: OR13.64 (1.21–153.33), p = 0.034].Conclusion: In this exploratory study, we identified biomarkers involved in inflammation, fibrosis and calcification which may be associated with having AVC. Biomarkers involved in fibrosis may show higher expression in females, whilst biomarkers involved in inflammation and calcification could associate with AVC in males.

KW - aortic valve calcification

KW - biomarkers

KW - sex-specific

KW - fibrosis

KW - inflammation

U2 - 10.3389/fcell.2020.00604

DO - 10.3389/fcell.2020.00604

M3 - Article

VL - 8

JO - Frontiers in cell and developmental biology

JF - Frontiers in cell and developmental biology

SN - 2296-634X

M1 - 604

ER -